NCT03131050 Effectiveness Study of Scopolamine Combined With Escitalopram in Patients With MDD Status COMPLETED Phase PHASE4
NCT03128021 Neural Mechanisms of Monoaminergic Engagement in Late-life Depression Treatment Response (NEMO) Status COMPLETED Phase PHASE4
NCT03122158 Escitalopram in the Treatment of Adolescents With Major Depressive Disorder or Anxiety Disorders Status UNKNOWN Phase PHASE4
NCT03121573 Efficacy and Safety of Duloxetine Among Individuals With Depressive Disorder in a 12 Weeks Trial Status COMPLETED Phase NA
NCT03113968 ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD) Status COMPLETED Phase PHASE2/PHASE3
NCT03096886 Novel Neural Circuit Biomarkers of Major Depression Response to CCBT Status COMPLETED Phase NA
NCT03095820 Multidomain Intervention for Older Adults With Major Depressive Disorder Status COMPLETED Phase NA
NCT03093025 A Study to Evaluate the Safety and Efficacy of TS-121 as an Adjunctive Treatment for Major Depressive Disorder Status TERMINATED Phase PHASE2
NCT03088657 Design and Methods of the Mood Disorder Cohort Research Consortium (MDCRC) Study Status UNKNOWN Phase N/A
NCT03084042 Emotional Brain Networks & Cognitive Functioning in Depression and Anxiety Status UNKNOWN Phase N/A
NCT03078322 AV-101 as Adjunct Antidepressant Therapy in Patients With Major Depression Status COMPLETED Phase PHASE2
NCT03072823 Omega-3 Polyunsaturated Fatty Acids on Major Depressive Disorder in Patients With Cardiovascular Diseases Status COMPLETED Phase NA
NCT03067506 Cognitive and Mood Assessment Data in Major Depressive Disorder Using Digital Wearable Technology Status COMPLETED Phase N/A
NCT03065335 Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder Status RECRUITING Phase PHASE1
NCT03062267 Effectiveness of a Mobile Texting Intervention for People With Serious Mental Illness Status COMPLETED Phase NA